Skip to content

APOTHEEK GILIAS

Active Public limited companyfounded 1986active for 40 yearsMilsestraat 33, 3053 Oud-HeverleeKBO/BCE: BE 0429.191.940 subsidiary of #5 oldest company in Oud-Heverlee, Wholesale and retail trade sector

Lifetime

25 annual accounts with figures on one time axis, 40 filings since 1986
peak of €309,261 in 2024
€264,613▼ 14.4%
peak of €196,215 in 2016
€26,315▲ 20.6%
peak of €115,574 in 2025
€115,574▲ 0.3%
€492,318▼ 9.3%
peak of 2.4 FTE in 2019
2.1 FTEunchanged
Board1 name since 2021
1 director
Owners
99.87%
Documentsfilings and deeds
26-08-202626 days late
2025abbreviated format
Gross margin from €309,261 to €264,613Cash from €47,138 to €17,723

Key points

from the 2025 annual accounts

Equity

€115,574 ▲ 0.3%

APOTHEEK GILIAS has made a profit in every financial year since 2001.

Debts

€492,318 81% of the balance sheet
Financial debts 35%Suppliers 40%Taxes and wages 4%Other 21%

Of this, €478,303 falls due within a year.

Filings

40 annual accounts since 1986
AprilJune31 JulyOctober1990200020102020

Two of the last ten came late. The 2023 accounts came in latest, 31 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 3,986 companies had the same profile as APOTHEEK GILIAS has now. Each dot stands for 10 companies, two years later.

96.5%
were still trading
2.3%
stopped another way
1.1%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 10 to 30%
  • a profit under 5% of the balance sheet
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 3,986 companies, not a prediction for APOTHEEK GILIAS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 99.87%score equity €899,801 (2025) · annual accounts 2025 of
Board & ownership

Recent changes

New sole director appointed, resigned · acts as permanent representative · General meeting of 01-09-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0429191940
Company renamed to APOTHEEK GILIAS changes role from managing director to sole director · resigns as director · acts as permanent representative · General meeting of 23-01-2023 · Gazette deed
1 director appointed, 1 resignation, 1 reappointment resigns · reappointed · acts as permanent representative · General meeting of 31-12-2012 · Gazette deed
All 50 events

Comparable companies

same main activity, similar in size and age
Company
APOTHEEK GILIAS Oud-Heverlee €607,893 €264,613 19.0% 2.1
APOTHEEK DIERICKX Lochristi €647,194 €248,777 60.7% 2.1
NAVEAU-SMEETS Lint €552,659 €237,388 49.3% 2.1
APOTEEK DE COSTER Zaventem €578,522 €280,332 37.2% 1.8
APOTHEEK REYNAERTS Scherpenheuvel-Zichem €677,239 €272,853 35.3% 1.7
APOTHEEK HOOGMARTENS Leuven €564,667 €206,773 66.1% 2.1
APOTHEEK VANDERSTEEN Beersel €542,498 €262,972 33.6% 2.1

These companies have the same main activity as APOTHEEK GILIAS: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €542,000 and €677,000, founded between 1983 and 1994.

Official details

Source: KBO
Status
Active since 18-06-1986Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.036.100.6703053 Oud-Heverlee, since 15-07-1986
Financial year end
31 December
Peppol
Reachable since 24-11-2023
Company details

Annual accounts 2025

≈ €910,000estimated
€607,893▼ 7.6%
Employeeson 31-12-2025
2▼ 33.3%
Filing
Filed on 26-08-2026
Financials

Insights on APOTHEEK GILIAS

APOTHEEK GILIAS files the abbreviated format. That format states no turnover. The gross margin rose from €80,889 in 2001 to €264,613 in 2025.

The balance sheet grew most from 2013 to 2014 through fixed assets.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about APOTHEEK GILIAS

What is the company number of APOTHEEK GILIAS?
The company number of APOTHEEK GILIAS is 0429.191.940. The VAT number is the same number with BE in front: BE 0429.191.940.
Where is APOTHEEK GILIAS based?
The registered office is at Milsestraat 33, 3053 Oud-Heverlee.Company details
What does APOTHEEK GILIAS do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK GILIAS?
APOTHEEK GILIAS is a public limited company (NV).
When was APOTHEEK GILIAS founded?
APOTHEEK GILIAS was founded on 18-06-1986.
Is APOTHEEK GILIAS still active?
Yes, APOTHEEK GILIAS is an active enterprise in the KBO register.
How many employees does APOTHEEK GILIAS have?
APOTHEEK GILIAS had an average of 2.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does APOTHEEK GILIAS fall under?
In its 2025 annual accounts, APOTHEEK GILIAS states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of APOTHEEK GILIAS?
The turnover in financial year 2025 is about €910,000. This figure is estimated from the gross margin of €264,613 and 42 comparable companies (NACE 477). It probably lies between €720,000 and €1.3m.
Is APOTHEEK GILIAS profitable?
In financial year 2025, APOTHEEK GILIAS made a profit of €26,315.
Where can I find the annual accounts of APOTHEEK GILIAS?
APOTHEEK GILIAS filed 40 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK GILIAS due?
APOTHEEK GILIAS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.